Effect and safety of Microneedling in the treatment of Frontal Fibrosing Alopecia

Not Applicable

Recruiting

• Conditions: Frontal Fibrosing alopeciaCicatricial alopecia; C17.800.329.937.122

• Registration Number: RBR-9jwgkv
• Lead Sponsor: Hospital Universitário Walter Cantídeo Universidade Federal do Ceará

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-28
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients with clinical diagnosis of Frontal fibrosing alopecia will be selected, including those with increased frontotemporal recess, associated or not with follicular papules and rarefaction of eyebrows; or histopathological diagnosis compatible with frontal fibrosing alopecia with follow up appointments at the Dermatology Department of Walter Cantideo University Hospital. Patients must be aged between 18 and 70 years old and must sign who the Informed Consent Form (ICF), with availability to attend periodic appointment evaluations.

Exclusion Criteria

Patients with the following conditions will be excluded: Pregnancy; Vitiligo, psoriasis or other skin diseases that present Koebner's phenomenon (development of chronic dermatosis in trauma areas); Active infections in the areas to be treated with microneedling; Presence of keloids in previous scars; History of allergy to topical or injectable anesthetic; Patients with psychiatric disorders or other clinical diseases that contraindicate the procedure; Patients who refuse to sign the Informed Consent Form (ICF) or who are unable to attend to periodic appointment evaluations.

Study & Design

• Study Type: Intervention
• Study Design: Not specified